Relationship between the expression of cyclooxygenase-2 and survivin in primary pterygium

Molecular Vision

Volumn 15, Issue , 2009, Pages 458-463

  Maxia, Cristina ^a   Perra, Maria Teresa ^a   Demurtas, Paolo ^a   Minerba, Luigi ^a   Murtas, Daniela ^a   Piras, Franca ^a   Cabrera, Renè ^b   Ribatti, Domenico ^c   Sirigu, Paola ^a,d  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b UNIVERSIDAD DE CUENCA   (Ecuador)

^c UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^d Instituto del Cancer Solca   (Ecuador)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; SURVIVIN; BIRC5 PROTEIN, HUMAN; MICROTUBULE ASSOCIATED PROTEIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; EPITHELIUM; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PTERYGIUM; ADOLESCENT; METABOLISM; METHODOLOGY; MIDDLE AGED; STAINING; TISSUE DISTRIBUTION;

ADOLESCENT; ADULT; AGED; CYCLOOXYGENASE 2; EPITHELIUM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; PTERYGIUM; STAINING AND LABELING; TISSUE DISTRIBUTION; YOUNG ADULT;

EID: 64349105849     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Di Girolamo N, McCluskey P, Lloyd A, Coroneo MT, Wakefield D. Expression of MMPs and TIMPs in human pterygia and cultured pterygium epithelial cells. Invest Ophthalmol Vis Sci 2000; 41:671-9. [PMID: 10711680]
2. Pinkerton OD, Hokama Y, Shigemura LA. Immunologic basis for the pathogenesis of pterygium. Am J Ophthalmol 1984; 98:225-8. [PMID: 6383051]
3. Perra MT, Maxia C, Zucca I, Piras F, Sirigu P. Immunohistochemical study of human pterygium. Histol Histopathol 2002; 17:139-49. [PMID: 11813864]
4. Tan DT, Tang WY, Liu YP, Goh HS, Smith DR. Apoptosis and apoptosis related gene expression in normal conjunctiva and pterygium. Br J Ophthalmol 2000; 84:212-6. [PMID: 10655200]
5. Maxia C, Perra MT, Demurtas P, Minerba L, Murtas D, Piras F, Corbu A, Gotuzzo DC, Cabrera GR, Ribatti D, Sirigu P. Expression of survivin protein in pterygium and relationship with oxidative DNA damage. J Cell Mol Med 2008; 12:2372-80. [PMID: 18266976]
6. Di Girolamo N, Kumar RK, Coroneo MT, Wakefield D. UVBmediated induction of interleukin-6 and −8 in pterygia and cultured human pterygium epithelial cells. Invest Ophthalmol Vis Sci 2002; 43:3430-7. [PMID: 12407153]
7. Kria L, Ohira A, Amemiya T. Growth factors in cultured pterygium fibroblasts: immunohistochemical and ELISA analysis. Graefes Arch Clin Exp Ophthalmol 1998; 236:702-8. [PMID: 9782432]
8. Ribatti D, Nico B, Maxia C, Longo V, Murtas D, Mangieri D, Perra MT, De Giorgis M, Piras F, Crivellato E, Sirigu P. Neovascularization and mast cells with tryptase activity increase simultaneously in human pterygium. J Cell Mol Med 2007; 11:585-9. [PMID: 17635650]
9. Detorakis ET, Drakonaki EE, Spandidos DA. Molecular genetic alterations and viral presence in ophthalmic pterygium. Int J Mol Med 2000; 6:35-41. [PMID: 10851263]
10. Piras F, Moore PS, Ugalde J, Perra MT, Scarpa A, Sirigu P. Detection of human papillomavirus DNA in pterygia from different geographical regions. Br J Ophthalmol 2003; 87:864-6. [PMID: 12812887]
11. Chui J, Di Girolamo N, Wakefield D, Coroneo MT. The pathogenesis of pterygium: current concepts and their therapeutic implications. Ocul Surf 2008; 6:24-43. [PMID: 18264653]
12. Chiang CC, Cheng YW, Lin CL, Lee H, Tsai FJ, Tseng SH, Tsai YY. Cyclooxygenase 2 expression in pterygium. Mol Vis 2007; 13:635-8. [PMID: 17515883]
13. Di Girolamo N, Wakefield D, Coroneo MT. UVB-mediated induction of cytokines and growth factors in pterygium epithelial cells involves cell surface receptors and intracellular signaling. Invest Ophthalmol Vis Sci 2006; 47:2430-7. [PMID: 16723453]
14. Detorakis ET, Zafiropoulos A, Arvanitis DA, Spandidos DA. Detection of point mutations at codon 12 of KI-ras in ophthalmic pterygia. Eye 2005; 19:210-4. [PMID: 15232598]
15. Tsai YY, Cheng YW, Lee H, Tsai FJ, Tseng SH, Lin CL, Chang KC. Oxidative DNA damage in pterygium. Mol Vis 2005; 11:71-5. [PMID: 15692461]
16. Reisman D, McFadden JW, Lu G. Loss of heterozygosity and p53 expression in pterygium. Cancer Lett 2004; 206:77-83. [PMID: 15019163]
17. Dushku N, Reid TW. P53 expression in altered limbal basal cells of pingueculae, pterygia, and limbal tumors. Curr Eye Res 1997; 16:1179-92. [PMID: 9426949]
18. Tan DT, Lim AS, Goh HS, Smith DR. Abnormal expression of the p53 tumor suppressor gene in the conjunctiva of patients with pterygium. Am J Ophthalmol 1997; 123:404-5. [PMID: 9063255]
19. Tsai YY, Cheng YW, Lee H, Tsai FJ, Tseng SH, Chang KC. P53 gene mutation spectrum and the relationship between gene mutation and protein levels in pterygium. Mol Vis 2005; 11:50-5. [PMID: 15682042]
20. Schneider BG, John-Aryankalayil M, Rowsey JJ, Dushku N, Reid TW. Accumulation of p53 protein in pterygia is not accompanied by TP53 gene mutation. Exp Eye Res 2006; 82:91-8. [PMID: 16005868]
21. Perra MT, Maxia C, Corbu A, Minerba L, Demurtas P, Colombari R, Murtas D, Bravo S, Piras F, Sirigu P. Oxidative stress in pterygium: relationship between p53 and 8- hydroxydeoxyguanosine. Mol Vis 2006; 12:1136-42. [PMID: 17093398]
22. Perra MT, Colombari R, Maxia C, Zucca I, Piras F, Corbu A, Bravo S, Scarpa A, Sirigu P. Finding of conjunctival melanocytic pigmented lesions within pterygium. Histopathology 2006; 48:387-93. [PMID: 16487360]
23. Bickers DR, Athar M. Oxidative stress in the pathogenesis of skin disease. J Invest Dermatol 2006; 126:2565-75. [PMID: 17108903]
24. Sarkar FH, Adsule S, Li Y, Padhye S. Back to the future: COX-2 inhibitors for chemoprevention and cancer therapy. Mini Rev Med Chem 2007; 7:599-608. [PMID: 17584158]
25. Herschman HR. Prostaglandin synthase 2. Biochim Biophys Acta 1996; 1299:125-40. [PMID: 8555245]
26. Rundhaug JE, Fischer SM. Cyclo-oxygenase-2 plays a critical role in UV-induced skin carcinogenesis. Photochem Photobiol 2008; 84:322-9. [PMID: 18194346]
27. Subbaramaiah K, Altorki N, Chung WJ, Mestre JR, Sampat A, Dannenberg AJ. Inhibition of cyclooxygenase-2 gene expression by p53. J Biol Chem 1999; 274:10911-5. [PMID: 10196169]
28. Koki AT, Khan NK, Woerner BM, Seibert K, Harmon JL, Dannenberg AJ, Soslow RA, Masferrer JL. Characterization of cyclooxygenase-2 (COX-2) during tumorigenesis in human epithelial cancers: evidence for potential clinical utility of COX-2 inhibitors in epithelial cancers. Prostaglandins Leukot Essent Fatty Acids 2002; 66:13-8. [PMID: 12051953]
29. Aziz MH, Ghotra AS, Shukla Y, Ahmad N. Ultraviolet-B radiation causes an upregulation of survivin in human keratinocytes and mouse skin. Photochem Photobiol 2004; 80:602-8. [PMID: 15623349]
30. Krysan K, Merchant FH, Zhu L, Dohadwala M, Luo J, Lin Y. Heuze-Vourc'h N, Põld M, Seligson D, Chia D, Goodglick L, Wang H, Strieter R, Sharma S, Dubinett S. COX-2-dependent stabilization of survivin in non-small cell lung cancer. FASEB J 2004; 18:206-8. [PMID: 14597555]
31. Barnes N, Haywood P, Flint P, Knox WF, Bundred NJ. Survivin expression in in situ and invasive breast cancer relates to COX-2 expression and DCIS recurrence. Br J Cancer 2006; 94:253-8. [PMID: 16421596]
32. Athanassiadou P, Grapsa D, Athanassiades P, Gonidi M, Athanassiadou AM, Tsipis A, Patsouris E. The prognostic significance of COX-2 and survivin expression in ovarian cancer. Pathol Res Pract 2008; 204:241-9. [PMID: 18171606]
33. Hattori Y, Nishigori C, Tanaka T, Uchida K, Nikaido O, Osawa T, Hiai H, Imamura S, Toyokuni S. 8-hydroxy-2'- deoxyguanosine is increased in epidermal cells of hairless mice after chronic ultraviolet B exposure. J Invest Dermatol 1996; 107:733-7. [PMID: 8875958]
34. Wilgus TA, Koki AT, Zweifel BS, Kusewitt DF, Rubal PA, Oberyszyn TM. Inhibition of cutaneous ultraviolet Bmediated inflammation and tumor formation with topical celecoxib treatment. Mol Carcinog 2003; 38:49-58. [PMID: 14502644]
35. Lu YP, Lou YR, Yen P, Mitchell D, Huang MT, Conney AH. Time course for early adaptive responses to ultraviolet B light in the epidermis of SKH-1 mice. Cancer Res 1999; 59:4591-602. [PMID: 10493513]
36. Kraemer KH. Sunlight and skin cancer: another link revealed. Proc Natl Acad Sci USA 1997; 94:11-4. [PMID: 8990152]
37. Ouhtit A, Muller HK, Gorny A, Ananthaswamy HN. UVBinduced experimental carcinogenesis: dysregulation of apoptosis and p53 signalling pathway. Redox Rep 2000; 5:128-9. [PMID: 10939292]
38. Buckman SY, Gresham A, Hale P, Hruza G, Anast J, Masferrer J, Pentland AP. COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer. Carcinogenesis 1998; 19:723-9. [PMID: 9635856]
39. Joo YE, Chung IJ, Park YK, Koh YS, Lee JH, Park CH, Lee WS, Kim HS, Choi SK, Rew JS, Park CS, Kim SJ. Expression of cyclooxygenase-2, p53 and Ki-67 in gastric cancer. J Korean Med Sci 2006; 21:871-6. [PMID: 17043422]
40. Tjiu JW, Liao YH, Lin SJ, Huang YL, Tsai WL, Chu CY, Kuo ML, Jee SH. Cyclooxygenase-2 overexpression in human basal cell carcinoma cell line increases antiapoptosis, angiogenesis, and tumorigenesis. J Invest Dermatol 2006; 126:1143-51. [PMID: 16528365]
41. Clear AS, Chirambo MC, Hutt MS. Solar keratosis, pterygium, and squamous cell carcinoma of the conjunctiva in Malawi. Br J Ophthalmol 1979; 63:102-9. [PMID: 427069]
42. Park TK, Jin KH. Telomerase activity in pterygeal and normal conjunctival epithelium. Korean J Ophthalmol 2000; 14:85-9. [PMID: 11213740]
43. Altieri DC. Survivin, cancer networks and pathway-directed drug discovery. Nat Rev Cancer 2008; 8:61-70. [PMID: 18075512]
44. Zaffaroni N, Pennati M, Colella G, Perego P, Supino R, Gatti L, Pilotti S, Zunino F, Daidone MG. Expression of the antiapoptotic gene survivin correlates with taxol resistance in human ovarian cancer. Cell Mol Life Sci 2002; 59:1406-12. [PMID: 12363043]
45. Erkanli S, Bolat F, Kayaselcuk F, Demirhan B, Kuscu E. COX-2 and survivin are overexpressed and positively correlated in endometrial carcinoma. Gynecol Oncol 2007; 104:320-5. [PMID: 17030351]